APO Research, Inc.

APO RESEARCH · REPORT

EPA & DHA (Omega 3) Ingredients

Selected research

Market Structure

Global EPA & DHA (Omega 3) Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global EPA & DHA (Omega 3) Ingredients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EPA & DHA (Omega 3) Ingredients include Lonza, Omega Protein, Martek, GC Rieber Oils, DSM, Croda, BASF, Axellus and Algae EPAX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EPA & DHA (Omega 3) Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EPA & DHA (Omega 3) Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EPA & DHA (Omega 3) Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA & DHA (Omega 3) Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.

EPA & DHA (Omega 3) Ingredients Segment by Company

Lonza

Omega Protein

Martek

GC Rieber Oils

DSM

Croda

BASF

Axellus

Algae EPAX

Aker BioMarine

EPA & DHA (Omega 3) Ingredients Segment by Type

Low Concentrates

Anchovy/Sardine

High Concentrates

Salmon Oil

Algae Oil

Cod Liver Oil

Medium Concentrates

EPA & DHA (Omega 3) Ingredients Segment by Application

Infant Formulas

Pharmaceuticals

Dietary Supplements

Functional Foods

Pet & Animal Feed

EPA & DHA (Omega 3) Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA (Omega 3) Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA (Omega 3) Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA (Omega 3) Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA & DHA (Omega 3) Ingredients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EPA & DHA (Omega 3) Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of EPA & DHA (Omega 3) Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of EPA & DHA (Omega 3) Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. EPA & DHA (Omega 3) Ingredients Industry Trends Table 2. EPA & DHA (Omega 3) Ingredients Industry Drivers Table 3. EPA & DHA (Omega 3) Ingredients Industry Opportunities and Challenges Table 4. EPA & DHA (Omega 3) Ingredients Industry Restraints Table 5. Global EPA & DHA (Omega 3) Ingredients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Manufacturers (2021-2026) Table 7. Global EPA & DHA (Omega 3) Ingredients Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Manufacturers Table 9. Global EPA & DHA (Omega 3) Ingredients Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global EPA & DHA (Omega 3) Ingredients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global EPA & DHA (Omega 3) Ingredients Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global EPA & DHA (Omega 3) Ingredients Manufacturers, Product Type & Application Table 13. Global EPA & DHA (Omega 3) Ingredients Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global EPA & DHA (Omega 3) Ingredients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Low Concentrates Table 17. Major Manufacturers of Anchovy/Sardine Table 18. Major Manufacturers of High Concentrates Table 19. Major Manufacturers of Salmon Oil Table 20. Major Manufacturers of Algae Oil Table 21. Major Manufacturers of Cod Liver Oil Table 22. Major Manufacturers of Medium Concentrates Table 23. Global EPA & DHA (Omega 3) Ingredients Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 24. Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026) & (k tons) Table 25. Global EPA & DHA (Omega 3) Ingredients Sales by Type (2027-2032) & (k tons) Table 26. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026) Table 27. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2027-2032) Table 28. Global EPA & DHA (Omega 3) Ingredients Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 29. Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2021-2026) & (k tons) Table 30. Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2027-2032) & (k tons) Table 31. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2021-2026) Table 32. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Infant Formulas Table 34. Major Manufacturers of Pharmaceuticals Table 35. Major Manufacturers of Dietary Supplements Table 36. Major Manufacturers of Functional Foods Table 37. Major Manufacturers of Pet & Animal Feed Table 38. Global EPA & DHA (Omega 3) Ingredients Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 39. Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026) & (k tons) Table 40. Global EPA & DHA (Omega 3) Ingredients Sales by Application (2027-2032) & (k tons) Table 41. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2026) Table 42. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2027-2032) Table 43. Global EPA & DHA (Omega 3) Ingredients Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 44. Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2021-2026) & (k tons) Table 45. Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2027-2032) & (k tons) Table 46. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application (2021-2026) Table 47. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application (2027-2032) Table 48. Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 49. Global EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2026) & (k tons) Table 50. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Region (2021-2026) Table 51. Global EPA & DHA (Omega 3) Ingredients Sales Forecasted by Region (2027-2032) & (k tons) Table 52. Global EPA & DHA (Omega 3) Ingredients Sales Forecasted Market Share by Region (2027-2032) Table 53. North America EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. North America EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (k tons) Table 55. North America EPA & DHA (Omega 3) Ingredients Sales by Country (2027-2032) & (k tons) Table 56. Europe EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. Europe EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (k tons) Table 58. Europe EPA & DHA (Omega 3) Ingredients Sales by Country (2027-2032) & (k tons) Table 59. Asia Pacific EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 60. Asia Pacific EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (k tons) Table 61. Asia Pacific EPA & DHA (Omega 3) Ingredients Sales by Country (2027-2032) & (k tons) Table 62. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 63. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (k tons) Table 64. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales by Country (2027-2032) & (k tons) Table 65. Global EPA & DHA (Omega 3) Ingredients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global EPA & DHA (Omega 3) Ingredients Revenue by Region (2021-2026) & (US$ Million) Table 67. Global EPA & DHA (Omega 3) Ingredients Revenue by Region (2027-2032) & (US$ Million) Table 68. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Region (2021-2026) Table 69. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Region (2027-2032) Table 70. Lonza Company Information Table 71. Lonza Business Overview Table 72. Lonza EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Lonza EPA & DHA (Omega 3) Ingredients Product Portfolio Table 74. Lonza Recent Development Table 75. Omega Protein Company Information Table 76. Omega Protein Business Overview Table 77. Omega Protein EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolio Table 79. Omega Protein Recent Development Table 80. Martek Company Information Table 81. Martek Business Overview Table 82. Martek EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Martek EPA & DHA (Omega 3) Ingredients Product Portfolio Table 84. Martek Recent Development Table 85. GC Rieber Oils Company Information Table 86. GC Rieber Oils Business Overview Table 87. GC Rieber Oils EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. GC Rieber Oils EPA & DHA (Omega 3) Ingredients Product Portfolio Table 89. GC Rieber Oils Recent Development Table 90. DSM Company Information Table 91. DSM Business Overview Table 92. DSM EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. DSM EPA & DHA (Omega 3) Ingredients Product Portfolio Table 94. DSM Recent Development Table 95. Croda Company Information Table 96. Croda Business Overview Table 97. Croda EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Croda EPA & DHA (Omega 3) Ingredients Product Portfolio Table 99. Croda Recent Development Table 100. BASF Company Information Table 101. BASF Business Overview Table 102. BASF EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. BASF EPA & DHA (Omega 3) Ingredients Product Portfolio Table 104. BASF Recent Development Table 105. Axellus Company Information Table 106. Axellus Business Overview Table 107. Axellus EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Axellus EPA & DHA (Omega 3) Ingredients Product Portfolio Table 109. Axellus Recent Development Table 110. Algae EPAX Company Information Table 111. Algae EPAX Business Overview Table 112. Algae EPAX EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Algae EPAX EPA & DHA (Omega 3) Ingredients Product Portfolio Table 114. Algae EPAX Recent Development Table 115. Aker BioMarine Company Information Table 116. Aker BioMarine Business Overview Table 117. Aker BioMarine EPA & DHA (Omega 3) Ingredients Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Aker BioMarine EPA & DHA (Omega 3) Ingredients Product Portfolio Table 119. Aker BioMarine Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. EPA & DHA (Omega 3) Ingredients Distributors List Table 123. EPA & DHA (Omega 3) Ingredients Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. EPA & DHA (Omega 3) Ingredients Product Image Figure 2. Global EPA & DHA (Omega 3) Ingredients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA & DHA (Omega 3) Ingredients Market Size (2021-2032) & (US$ Million) Figure 4. Global EPA & DHA (Omega 3) Ingredients Sales (2021-2032) & (k tons) Figure 5. Global EPA & DHA (Omega 3) Ingredients Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 EPA & DHA (Omega 3) Ingredients Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Low Concentrates Image Figure 9. Anchovy/Sardine Image Figure 10. High Concentrates Image Figure 11. Salmon Oil Image Figure 12. Algae Oil Image Figure 13. Cod Liver Oil Image Figure 14. Medium Concentrates Image Figure 15. Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 16. Global EPA & DHA (Omega 3) Ingredients Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2032) Figure 18. Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 19. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2021-2032) Figure 21. Infant Formulas Image Figure 22. Pharmaceuticals Image Figure 23. Dietary Supplements Image Figure 24. Functional Foods Image Figure 25. Pet & Animal Feed Image Figure 26. Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 27. Global EPA & DHA (Omega 3) Ingredients Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2032) Figure 29. Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 30. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application (2021-2032) Figure 32. North America EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 33. North America EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2032) Figure 34. U.S. EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 35. Canada EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Mexico EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Europe EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Europe EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2032) Figure 39. Germany EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 40. France EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 41. U.K. EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Italy EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Netherlands EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 44. Asia Pacific EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Asia Pacific EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2032) Figure 46. China EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 47. Japan EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 48. South Korea EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 49. Southeast Asia EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 50. India EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Australia EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 52. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 53. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2032) Figure 54. Brazil EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 55. South Africa EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 57. Turkey EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 58. Argentina EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 59. UAE EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 60. Egypt EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 61. Chile EPA & DHA (Omega 3) Ingredients Sales and Growth Rate (2021-2032) & (k tons) Figure 62. Global EPA & DHA (Omega 3) Ingredients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America EPA & DHA (Omega 3) Ingredients Revenue (2021-2032) & (US$ Million) Figure 65. North America EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe EPA & DHA (Omega 3) Ingredients Revenue (2021-2032) & (US$ Million) Figure 67. Europe EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific EPA & DHA (Omega 3) Ingredients Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. EPA & DHA (Omega 3) Ingredients Value Chain Figure 73. Manufacturing Cost Structure Figure 74. EPA & DHA (Omega 3) Ingredients Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Low Concentrates
  • Anchovy/Sardine
  • High Concentrates
  • Salmon Oil
  • Algae Oil
  • Cod Liver Oil
  • Medium Concentrates
Applications
  • Infant Formulas
  • Pharmaceuticals
  • Dietary Supplements
  • Functional Foods
  • Pet & Animal Feed
Companies covered
  • Lonza
  • Omega Protein
  • Martek
  • GC Rieber Oils
  • DSM
  • Croda
  • BASF
  • Axellus
  • Algae EPAX
  • Aker BioMarine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global EPA & DHA (Omega 3) Ingredients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global EPA & DHA (Omega 3) Ingredients Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global EPA & DHA (Omega 3) Ingredients Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global EPA & DHA (Omega 3) Ingredients Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global EPA & DHA (Omega 3) Ingredients Market Dynamics
  1. 2.1 EPA & DHA (Omega 3) Ingredients Industry Trends
  2. 2.2 EPA & DHA (Omega 3) Ingredients Industry Drivers
  3. 2.3 EPA & DHA (Omega 3) Ingredients Industry Opportunities and Challenges
  4. 2.4 EPA & DHA (Omega 3) Ingredients Industry Restraints
3 EPA & DHA (Omega 3) Ingredients Market by Manufacturers
  1. 3.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Manufacturers (2021-2026)
  2. 3.2 Global EPA & DHA (Omega 3) Ingredients Sales by Manufacturers (2021-2026)
  3. 3.3 Global EPA & DHA (Omega 3) Ingredients Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global EPA & DHA (Omega 3) Ingredients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global EPA & DHA (Omega 3) Ingredients Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global EPA & DHA (Omega 3) Ingredients Manufacturers, Product Type & Application
  7. 3.7 Global EPA & DHA (Omega 3) Ingredients Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global EPA & DHA (Omega 3) Ingredients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 EPA & DHA (Omega 3) Ingredients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 EPA & DHA (Omega 3) Ingredients Tier 1, Tier 2, and Tier 3
4 EPA & DHA (Omega 3) Ingredients Market by Type
  1. 4.1 EPA & DHA (Omega 3) Ingredients Type Introduction
  2. 4.1.1 Low Concentrates
  3. 4.1.2 Anchovy/Sardine
  4. 4.1.3 High Concentrates
  5. 4.1.4 Salmon Oil
  6. 4.1.5 Algae Oil
  7. 4.1.6 Cod Liver Oil
  8. 4.1.7 Medium Concentrates
  9. 4.2 Global EPA & DHA (Omega 3) Ingredients Sales by Type
  10. 4.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2032)
  12. 4.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2032)
  13. 4.3 Global EPA & DHA (Omega 3) Ingredients Revenue by Type
  14. 4.3.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2021-2032)
  16. 4.3.3 Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2021-2032)
5 EPA & DHA (Omega 3) Ingredients Market by Application
  1. 5.1 EPA & DHA (Omega 3) Ingredients Application Introduction
  2. 5.1.1 Infant Formulas
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Functional Foods
  6. 5.1.5 Pet & Animal Feed
  7. 5.2 Global EPA & DHA (Omega 3) Ingredients Sales by Application
  8. 5.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2032)
  10. 5.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2032)
  11. 5.3 Global EPA & DHA (Omega 3) Ingredients Revenue by Application
  12. 5.3.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2021-2032)
  14. 5.3.3 Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application (2021-2032)
6 Global EPA & DHA (Omega 3) Ingredients Sales by Region
  1. 6.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2032)
  3. 6.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2026)
  4. 6.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global EPA & DHA (Omega 3) Ingredients Revenue by Region
  1. 7.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Region
  2. 7.1.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Region (2021-2026)
  4. 7.1.3 Global EPA & DHA (Omega 3) Ingredients Revenue by Region (2027-2032)
  5. 7.1.4 Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America EPA & DHA (Omega 3) Ingredients Revenue (2021-2032)
  8. 7.2.2 North America EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe EPA & DHA (Omega 3) Ingredients Revenue (2021-2032)
  11. 7.3.2 Europe EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific EPA & DHA (Omega 3) Ingredients Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa EPA & DHA (Omega 3) Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza EPA & DHA (Omega 3) Ingredients Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 Omega Protein
  8. 8.2.1 Omega Protein Company Information
  9. 8.2.2 Omega Protein Business Overview
  10. 8.2.3 Omega Protein EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolio
  12. 8.2.5 Omega Protein Recent Developments
  13. 8.3 Martek
  14. 8.3.1 Martek Company Information
  15. 8.3.2 Martek Business Overview
  16. 8.3.3 Martek EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Martek EPA & DHA (Omega 3) Ingredients Product Portfolio
  18. 8.3.5 Martek Recent Developments
  19. 8.4 GC Rieber Oils
  20. 8.4.1 GC Rieber Oils Company Information
  21. 8.4.2 GC Rieber Oils Business Overview
  22. 8.4.3 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Product Portfolio
  24. 8.4.5 GC Rieber Oils Recent Developments
  25. 8.5 DSM
  26. 8.5.1 DSM Company Information
  27. 8.5.2 DSM Business Overview
  28. 8.5.3 DSM EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DSM EPA & DHA (Omega 3) Ingredients Product Portfolio
  30. 8.5.5 DSM Recent Developments
  31. 8.6 Croda
  32. 8.6.1 Croda Company Information
  33. 8.6.2 Croda Business Overview
  34. 8.6.3 Croda EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Croda EPA & DHA (Omega 3) Ingredients Product Portfolio
  36. 8.6.5 Croda Recent Developments
  37. 8.7 BASF
  38. 8.7.1 BASF Company Information
  39. 8.7.2 BASF Business Overview
  40. 8.7.3 BASF EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BASF EPA & DHA (Omega 3) Ingredients Product Portfolio
  42. 8.7.5 BASF Recent Developments
  43. 8.8 Axellus
  44. 8.8.1 Axellus Company Information
  45. 8.8.2 Axellus Business Overview
  46. 8.8.3 Axellus EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Axellus EPA & DHA (Omega 3) Ingredients Product Portfolio
  48. 8.8.5 Axellus Recent Developments
  49. 8.9 Algae EPAX
  50. 8.9.1 Algae EPAX Company Information
  51. 8.9.2 Algae EPAX Business Overview
  52. 8.9.3 Algae EPAX EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Algae EPAX EPA & DHA (Omega 3) Ingredients Product Portfolio
  54. 8.9.5 Algae EPAX Recent Developments
  55. 8.10 Aker BioMarine
  56. 8.10.1 Aker BioMarine Company Information
  57. 8.10.2 Aker BioMarine Business Overview
  58. 8.10.3 Aker BioMarine EPA & DHA (Omega 3) Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aker BioMarine EPA & DHA (Omega 3) Ingredients Product Portfolio
  60. 8.10.5 Aker BioMarine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EPA & DHA (Omega 3) Ingredients Value Chain Analysis
  2. 9.1.1 EPA & DHA (Omega 3) Ingredients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EPA & DHA (Omega 3) Ingredients Production Mode & Process
  6. 9.2 EPA & DHA (Omega 3) Ingredients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EPA & DHA (Omega 3) Ingredients Distributors
  9. 9.2.3 EPA & DHA (Omega 3) Ingredients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.